Lucidin from Rubia cordifolia Outperforms FDA-Approved Lapatinib as a Potential Multitargeted Candidate for Breast Cancer Signalling Proteins
- Akram Ahmed Aloqbi
- , Hadil Alahdal
- , Amany I. Alqosaibi
- , Mashael M. Alnamshan
- , Ibtesam S. Al-Dhuayan
- , Ahood A. Al-Eidan
- , Hind A.S. Alzahrani
- , Nouf K. ALaqeel
- , Fatmah Hazza Alsharif
- , Abeer Al Tuwaijri*
*Corresponding author for this work
- University of Jeddah
- Princess Nourah Bint Abdulrahman University
- King Abdulaziz University
- Ministry of National Guard Health Affairs
- King Saud bin Abdulaziz University for Health Sciences
Research output: Contribution to journal › Article › peer-review
4
Link opens in a new tab
Scopus
citations